from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2052c/-

LFCtreatmentdescriptionclass of inhibitor

-0.109

Amikacinug/mL Amikacintranslation

0.025

Cap5-10ug/mL Capreomycintranslation

-0.001

Rox10-50 ug/mL Roxithromycintranslation

0.471

SM2-5 ug/mL Streptomycintranslation

-0.173

Tet5-10 ug/mL Tetracyclinetranslation

-0.820

Rif0.2-5ug/mL Rifampicintranscription

-0.043

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.151

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.541

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.220

CPZ10-50 ug/mL Chlorpromazinerespiration

0.774

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.536

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.785

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.484

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.005

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.118

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.528

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.818

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.350

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.250

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.640

KCN5-20 ug/mL Potassium cyaniderespiration

-0.198

NaN30.2-2 mM Sodium aziderespiration

-0.795

Nigericin50 uM Nigericinrespiration

-0.774

TRC10-150 ug/mL Triclosanrespiration

0.493

TRZ10-25 ug/mL Thioridazinerespiration

-0.574

Valinomycin0.5-10 uM Valinomycinrespiration

0.090

ZnSO42 mM ZnSO4respiration

0.340

menadione6-10 ug/mL Menadionerespiration

0.148

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.445

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.408

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.766

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.193

NRP_1Non-replicating persistence stage 1dosRassociated

0.059

Amp0.2mg/mL AmpicillincellWall

-0.114

Cephalexin20-100 ug/mL CephalexincellWall

-0.174

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.775

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

0.177

Eta12-40 ug/mL EthionamidecellWall

-0.117

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.069

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.039

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.723

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.396

BZA0.12 mg/mL BenzamidearomaticAmides

0.343

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.671

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.260

H2O24 mM hydrogen peroxideDNAdamaging

-0.670

Levo10 ug/mL LevofloxacinDNAdamaging

0.038

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.335

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.696

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.091

UVUV-irradiationDNAdamaging

-0.912

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.988

Antimycin12.5-50 ug/mL Antimycin A?

-0.643

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.978

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.938

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.228

PA8240.2-2 ug/mL PA-824?

0.583

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.005

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.264

Verapamil50 uM Verapamil?

-0.873

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.272

methoxatin10-20 ug/mL Methoxatin?